High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion
This article has been Reviewed by the following groups
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
- Evaluated articles (ScreenIT)
Abstract
A deeper understanding of COVID‐19 on human molecular pathophysiology is urgently needed as a foundation for the discovery of new biomarkers and therapeutic targets. Here we applied mass spectrometry (MS)‐based proteomics to measure serum proteomes of COVID‐19 patients and symptomatic, but PCR‐negative controls, in a time‐resolved manner. In 262 controls and 458 longitudinal samples of 31 patients, hospitalized for COVID‐19, a remarkable 26% of proteins changed significantly. Bioinformatics analyses revealed co‐regulated groups and shared biological functions. Proteins of the innate immune system such as CRP, SAA1, CD14, LBP, and LGALS3BP decreased early in the time course. Regulators of coagulation (APOH, FN1, HRG, KNG1, PLG) and lipid homeostasis (APOA1, APOC1, APOC2, APOC3, PON1) increased over the course of the disease. A global correlation map provides a system‐wide functional association between proteins, biological processes, and clinical chemistry parameters. Importantly, five SARS‐CoV‐2 immunoassays against antibodies revealed excellent correlations with an extensive range of immunoglobulin regions, which were quantified by MS‐based proteomics. The high‐resolution profile of all immunoglobulin regions showed individual‐specific differences and commonalities of potential pathophysiological relevance.
Article activity feed
-
-
SciScore for 10.1101/2021.02.22.21252236: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Anonymized analysis has been approved by the Ethics Committee of LMU Munich (reference number 21-0047). Randomization not detected. Blinding not detected. Power Analysis To increase the statistical power for the identification of longitudinally changing proteins, we binned proteomes over a distinct time window of always five days: 1-5, 6-10, 11-15, 16-20, 21-25, 26-30, 31-35, 36-40, 41-45, 46-50, 51-54. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Bioinformatics analysis: Bioinformatics analyses were performed in Jupyter notebooks using Python and with the Perseus software of the MaxQuant computational … SciScore for 10.1101/2021.02.22.21252236: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement IRB: Anonymized analysis has been approved by the Ethics Committee of LMU Munich (reference number 21-0047). Randomization not detected. Blinding not detected. Power Analysis To increase the statistical power for the identification of longitudinally changing proteins, we binned proteomes over a distinct time window of always five days: 1-5, 6-10, 11-15, 16-20, 21-25, 26-30, 31-35, 36-40, 41-45, 46-50, 51-54. Sex as a biological variable not detected. Table 2: Resources
Software and Algorithms Sentences Resources Bioinformatics analysis: Bioinformatics analyses were performed in Jupyter notebooks using Python and with the Perseus software of the MaxQuant computational platform (22, 24). Perseussuggested: (Perseus, RRID:SCR_015753)MaxQuantsuggested: (MaxQuant, RRID:SCR_014485)To draft correlation plots (U-plots), the correlation of clinical to proteomics data was done with Python version 3.8.5. using Pandas (1.1.3), Numpy (1.19.2), Scipy (1.5.2) and Statsmodels (0.12.0) packages. Pythonsuggested: (IPython, RRID:SCR_001658)Numpysuggested: (NumPy, RRID:SCR_008633)Scipysuggested: (SciPy, RRID:SCR_008058)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We found bar graphs of continuous data. We recommend replacing bar graphs with more informative graphics, as many different datasets can lead to the same bar graph. The actual data may suggest different conclusions from the summary statistics. For more information, please see Weissgerber et al (2015).
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- Thank you for including a funding statement. Authors are encouraged to include this statement when submitting to a journal.
- No protocol registration statement was detected.
-
